BRCA2 and cancer: HR-deficiency is, therefore, a driver of tumorigenesis as demonstrated in cancer cells deficient in BRCA1- and BRCA2 (BRCA) expression or functions (Fackenthal and Olopade, 2007; Ramus and Gayther, 2009).